Historical salary details - Mr. Adrian Rawcliffe, Director and Chief Executive Officer, Adaptimmune Therapeutics Plc - ADR
Mr. Adrian Rawcliffe has been the Director and Chief Executive Officer of Adaptimmune Therapeutics Plc - ADR since 29 Apr 2019 and his latest salary was 2.1 M. View his historical salary.
Mr. Adrian Rawcliffe
Director and Chief Executive Officer
$ 2.1 M
Gross Remuneration
-
Current Company
Adaptimmune Therapeutics Plc - ADR
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Adaptimmune Therapeutics Plc - ADR | Director and Chief Executive Officer | 2.1 M | -24.0 % |
| 2023 | Adaptimmune Therapeutics Plc - ADR | - | 2.8 M | -18.6 % |
| 2022 | Adaptimmune Therapeutics Plc - ADR | Director and Chief Executive Officer | 3.4 M | -19.1 % |
| 2021 | Adaptimmune Therapeutics Plc - ADR | - | 4.2 M | 56.0 % |
| 2021 | Adaptimmune Therapeutics Plc - ADR | Director and Chief Executive Officer | 4.2 M | 56.0 % |
| 2020 | Adaptimmune Therapeutics Plc - ADR | - | 2.7 M | 25.8 % |
| 2020 | Adaptimmune Therapeutics Plc - ADR | Director and Chief Executive Officer | 2.7 M | 25.8 % |
| 2020 | Adaptimmune Therapeutics Plc - ADR | - | 2.7 M | 25.8 % |
| 2019 | Adaptimmune Therapeutics Plc - ADR | - | 2.2 M | 52.9 % |
| 2019 | Adaptimmune Therapeutics Plc - ADR | - | 2.2 M | 52.9 % |
| 2019 | Adaptimmune Therapeutics Plc - ADR | Director and Chief Executive Officer | 2.1 M | 52.4 % |
| 2018 | Adaptimmune Therapeutics Plc - ADR | - | 1.4 M | -7.7 % |
| 2018 | Adaptimmune Therapeutics Plc - ADR | - | 1.4 M | -8.2 % |
| 2018 | Adaptimmune Therapeutics Plc - ADR | Chief Financial Officer and Principal Accounting Officer | 1.4 M | -8.2 % |
| 2017 | Adaptimmune Therapeutics Plc - ADR | - | 1.5 M | 21.8 % |
| 2017 | Adaptimmune Therapeutics Plc - ADR | - | 1.5 M | 21.8 % |
| 2017 | Adaptimmune Therapeutics Plc - ADR | Chief Financial Officer and Principal Accounting Officer | 1.5 M | 21.8 % |
| 2016 | Adaptimmune Therapeutics Plc - ADR | - | 1.3 M | - |
| 2016 | Adaptimmune Therapeutics Plc - ADR | - | 1.3 M | - |
| 2016 | Adaptimmune Therapeutics Plc - ADR | Chief Financial Officer | 1.3 M | - |
| 2015 | Adaptimmune Therapeutics Plc - ADR | - | 2.9 M | - |
| 2015 | Adaptimmune Therapeutics Plc - ADR | - | 2.9 M | - |
| 2015 | Adaptimmune Therapeutics Plc - ADR | Chief Financial Officer | - | - |
| 2014 | Adaptimmune Therapeutics Plc - ADR | Chief Financial Officer | - | - |